Success of personalized ruxolitinib treatment based on therapeutic drug monitoring in pediatric patients with primary and secondary hemophagocytic lymphohistiocytosis allowing bridging to hsct

BONE MARROW TRANSPLANTATION(2023)

引用 0|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要